Alcohol is considered a leading risk factor for osteopenia. Our previous research indicated that the Akt/GSK-3b/b-catenin pathway plays a critical role in the ethanol-induced antiosteogenic effect in bone mesenchymal stem cells (BMSCs). PI3K/Akt is negatively regulated by the phosphatase and tensin homolog (PTEN) phosphatase. In this study, we found that ethanol increased PTEN expression in the BMSCs and bone tissue of ethanol-treated Sprague-Dawley rats. PTEN upregulation impaired Akt recruitment to the plasma membrane and suppressed Akt phosphorylation at Ser473, thereby inhibiting Akt/GSK3b/b-catenin signaling and the expression of COL1 and OCN in BMSCs in vitro and in vivo. The results of in vivo assays indicated that PTEN inhibition protected bone tissue against ethanol. Interestingly, our data revealed that following ethanol stimulation, PTEN and PTEN pseudogene 1 (PTENP1) mRNA expression was increased in a time-dependent manner, resulting in an increased PTEN protein level. In addition, ethanol upregulated PTEN expression and decreased PTEN phosphorylation (p-PTEN), indicating an increase in functional PTEN levels. In summary, the ethanol-mediated transcriptional and post-transcriptional regulation of PTEN impaired downstream Akt/GSK3b/b-catenin signaling and BMSC osteogenic differentiation. Therefore, we propose that Akt/GSK3b/b-catenin activation via PTEN inhibition may be a potential therapeutic approach for preventing the development of alcohol-induced osteopenia.
Introduction
Alcohol abuse is one of the leading risk factors for reduced bone mass and impaired bone structure [1] . Although the dose effect of alcohol consumption on the osteogenic response is controversial, which may be associated with variations in drinking habits and individual differences [2, 3] , chronic heavy alcohol Abbreviations ALP, alkaline phosphatase; ARS, alizarin red staining; BMD, bone mineral density; BMSCs, bone mesenchymal stem cells; BV/TV, bone volume per tissue volume; COL1, collagen 1; CT, computed tomography; DAPI, 4 0 ,6-diamidino-2-phenylindole; EDTA, ethylene diamine tetraacetic acid; EIA, enzyme immunoassay; FBS, fetal bovine serum; H&E, hematoxylin and eosin; IGF-1, insulin-like growth factor-1; MAR, mineral apposition rate; OCN, osteocalcin; p-PTEN, PTEN phosphorylation; PS, penicillin-streptomycin solution; PTENP1, PTEN pseudogene 1; PTEN, phosphatase and tensin homolog phosphatase; SPF, specific pathogen free; Tb.N, trabecular number; Tb.Sp, trabecular separation; Tb.Th, trabecular thickness.
consumption has generally negative effects on bone remodeling. Alcohol abuse may ultimately result in bone loss and increase the risk for osteoporosis and fracture.
To maintain homeostasis, bone is continuously undergoing a remodeling process in response to microdamage [4, 5] . Skeleton development and maintenance are mainly regulated by hormones acting on osteoblast and bone mesenchymal stem cells (BMSCs) [6] . Skeletal growth factors, such as insulin-like growth factor-1 (IGF-1), affect BMSC proliferation and lifespan by activating antiapoptotic pathways, increasing cell proliferation, and influencing differentiation [7] . Recent studies have shown that the PI3K-Akt signaling pathway has an important role in regulating bone development [8] . Akt activation promotes numerous cellular biological functions, including proliferation, differentiation, and survival by regulating a series of downstream signaling pathways [9] .
Phosphatase and tensin homolog phosphatase is a lipid phosphatase that negatively regulates the PI3K signaling pathway and is a tumor suppressor that regulates PI3K by dephosphorylating PIP3 [10] . Loss of PTEN function in osteoblasts results in PIP3 accumulation and persistent Akt activation, leading to increased osteogenic differentiation and proliferation [11] . However, the role of PTEN in BMSCs has not been completely understood.
Studies have demonstrated that in the human body, alcohol consumption impairs bone formation, resulting in osteopenia, delayed bone fracture healing, and bone nonunion. Previously, scientists have demonstrated that BMSCs [12] have reduced osteogenic differentiation and increased adipogenic differentiation potential following ethanol treatment [13] , which is consistent with our published findings [14] . Our published data indicate that the ethanol-mediated anti-osteogenic effect is associated with an impaired Akt/GSK-3b/ b-catenin pathway in BMSCs [14] . Interestingly, current investigations indicate that ethanol significantly increases PTEN expression in animal bodies [15] . Therefore, we hypothesized that the ethanol-induced impairment of BMSC osteogenic differentiation might be associated with increased PTEN activity and decreased Akt/GSK-3b/b-catenin pathway activity, the direct downstream target of PTEN.
To directly investigate the role of PTEN in bone formation, two specific PTEN inhibitors (SF1670 and VO-Ohpic) were used [16, 17] . Compared with rats in the alcohol-fed (AL) group, rats in the groups fed an alcohol diet in combination with intraperitoneal (i.p.) injections of PTEN inhibitors presented with a significant increase in bone volume and density. Compared with BMSCs from the AL group, BMSCs harvested from the PTEN inhibitor-treated groups demonstrated striking osteogenic differentiation capacity. These findings provide in vivo evidence that PTEN inhibition alleviates the alcohol-induced antiosteogenic effect via the Akt/GSK-3b/b-catenin pathway in BMSCs.
Results
Akt/GSK-3b/b-catenin pathway is downregulated by PTEN activation following ethanol treatment in BMSCs
Bone mesenchymal stem cells were identified by three lineage differentiations. The multilineage differentiation potential of the BMSCs used in the following experiments, to differentiate into osteogenic, chondrogenic, and adipogenic cells, was examined. Using Oil Red O staining, we verified adipogenic differentiation (Fig. 1A) ; alizarin red staining (ARS) indicated osteogenic differentiation (Fig. 1C) ; and the pellet test confirmed chondrogenic differentiation (Fig. 1E) . First, via western blotting, we investigated the effect of ethanol on the PTEN/Akt/GSK-3b/b-catenin pathway in BMSCs. Our data showed that ethanol treatment increased PTEN expression but suppressed the signaling of the downstream Akt/GSK-3b/b-catenin pathway ( Fig. 2A) . We also examined the activity of a different Akt kinase phosphorylation site, but the results indicated that Thr308 phosphorylation level was not significantly decreased by ethanol treatment as compared to the decrease in p-Akt-Ser473 ( Fig. 2A) . Figure 2B showed the quantification of Fig. 2A (n = 3, *P < 0.05). Therefore, we mainly focused on the PTEN/Akt-Ser473/ GSK-3b/b-catenin pathway in the following studies. Figure 2C depicts a schematic model of the effect of ethanol on the PTEN/Akt/GSK-3b/b-catenin pathway.
PTEN inhibition alleviated the ethanol-induced Akt/GSK-3b/b-catenin pathway suppression in BMSCs
To investigate the molecular mechanism underlying ethanol-induced PTEN/Akt/GSK-3b/b-catenin pathway suppression, we treated BMSCs with two selective PTEN inhibitors: SF1670 and VO-Ohpic [16] [17] [18] [19] . The results showed when cells were cotreated with PTEN inhibitors, the phosphorylation levels of Akt, GSK-3b and downstream b-catenin were rescued (Fig. 3A) . Even with higher concentrations of ethanol, PTEN inhibitors were sufficient to restore Akt/GSK-3b/ b-catenin pathway activation (Fig. 3A) . Figures 3B-D showed the quantification of Fig. 3A [n = 3, *P < 0.05 indicated significant difference as compared with Ethanol (50 mM) group]. However, when Akt phosphorylation was blocked with the selective inhibitor Ly294002, the rescue effect of PTEN inhibitors on the PTEN/Akt/GSK-3b/b-catenin pathway was abolished (Fig. 3E) . We next visualized Akt phosphorylation via immunofluorescence. Our results indicated the translocation of Akt to plasma membrane, as shown in the Insulin group (Fig. 4A) , was largely interrupted by ethanol treatment. However, when cells were treated with either SF1670 or VO-Ohpic, this inhibition was largely reversed (Fig. 4A ). This observation is consistent with Akt membrane localization as a prerequisite for Akt phosphorylation [20] . Akt translocation from the cytoplasm to the plasma membrane was blocked by ethanol, whereas PTEN inhibitors rescued this effect. Furthermore, quantification of the colocalization of Akt and cell skeleton was performed using IMAGEJ software (Fig. 4B-E) , as reported previously [21, 22] , and revealed a similar result. A BMSC was defined as an Akt-positive cell when an Akt molecule was recruited to membrane. The number of Akt-positive cells was calculated using IMAGEJ (Fig. 4F ). (*P < 0.05 as compared with the Insulin + Ethanol group, n = 60 cells per group (slice) with three replicates for each group). The Akt-positive cells were significantly decreased in Insulin + Ethanol group and increased in both Insulin + Ethanol + SF1670 and Insulin + Ethanol + VO-Ohpic groups.
As downstream targets of the PTEN/Akt axis, GSK-3b kinase and b-catenin levels were decreased by ethanol treatment. Therefore, we used two inhibitors of GSK-3b, CHIR-98014 and TWS119, to abolish this inhibitory effect. Western blotting assays showed CHIR-98014 and TWS119 treatment both rescued the ethanol-induced suppression of p-GSK3b and b-catenin levels without activating Akt kinase (Fig. 3F) . b-catenin protein is mainly degraded by GSK3b kinase via the ubiquitin-proteasome pathway, which is a critical biological process in b-catenin regulation. [23] ), SF1670 (500 nM), and VO-Ohpic (1 lM). The western blotting results revealed that the Akt/GSK-3b/b-catenin pathway was deactivated by ethanol treatment and that PTEN inhibitors rescued this inhibition. Gapdh was used as an internal reference (three replicates). (B-D) Analysis showed Akt/GSK-3b/ b-catenin pathway deactivated by ethanol was rescued by PTEN inhibition (n = 3, *P < 0.05) (E) When hBMSCs were treated with a selective PI3K inhibitor (Ly294002, 10 lM) and/or PTEN inhibitors for 24 h, the rescue effect of PTEN inhibitors was abolished. Gapdh was used as an internal reference (three replicates). (F) hBMSCs were treated with ethanol and/or GSK-3b inhibitors for 24 h. The western blotting results showed that TWS119 (5 lM) and CHIR-98014 (5 lM) rescued the ethanol-induced suppression of the GSK-3b/b-catenin axis. (three replicates). (G) The nuclear and cytoplasmic proteins of hBMSCs were separated. Ethanol decreased both nuclear and cytoplasmic b-catenin which were increased by SF1670 and VO-Ohpic treatment. hBMSCs were treated with 50 mM ethanol and/or SF1670 and VO-Ohpic for 24 h, and b-catenin expression in the cytoplasm and nucleus was assessed via western blotting. Gapdh was used as an internal reference for cytoplasmic proteins, and the expression of nuclear proteins was normalized to that of Histon-3. (Three replicates). (H) Analysis showed the expression of b-catenin in cytoplasm (n = 3, *P < 0.05 as compared with the Ethanol group). (I) Nuclear b-catenin was calculated and expressed as nuclear beta-catenin/(nuclear+ cytosolic beta-catenin) 9 100%, (n = 3, *P < 0.05 as compared with the Ethanol group). Error bars indicate SD.
GSK-3b kinase activation decreases b-catenin degradation while increasing b-catenin accumulation in the cytoplasm. [24] Then, b-catenin translocates into the cell nucleus to initiate the transcription of osteogenicrelated genes. [25] We separated the proteins in the nucleus from those in the cytoplasm. Cytoplasmic and nuclear b-catenin expression was shown in Fig. 3G and calculated in Fig. 3H . It was noticed that both cytoplasmic and nuclear b-catenin levels were decreased by ethanol and could be restored by SF1670/VO-Ohpic treatment. To quantify b-catenin nuclear translocation, we calculated the percentage of nuclear b-catenin expression (Fig. 3I , n = 3). Although ethanol decreased the absolute amount of cytoplasmic and nuclear b-catenin, the nuclear translocation of b-catenin was not affected relatively.
We next performed immunostaining of p-Akt (Ser473) on distal femur samples. Normally, BMSCs are recruited to bone synthesis sites adjacent to the trabecular bone and are induced into osteoblast cells in the osteogenic microenvironment [7] . Osteoblast cells are generally considered the major source for bone tissue formation [26] [27] [28] . Therefore, for in vivo investigations, we focused on osteoblast-like periosteal cells [7] . We found that the periosteal cells in the AL group presented with decreased phosphorylation levels, while the two groups with PTEN inhibitors demonstrated an increase in the number of p-Akt(Ser473)-positive periosteal cells (Fig. 4H ). Figure 4G depicted the quantification of p-Akt(Ser473)-positive periosteal cells in each group (n = 3, *P < 0.05).
Therefore, our results demonstrated that ethanol impaired the PTEN/Akt/GSK-3b/b-catenin pathway, resulting in b-catenin degradation. Reduced accumulation of b-catenin ultimately decreased transcription of osteogenic-related genes, which could be reversed by PTEN inhibition.
The ethanol-induced PTEN/Akt/GSK-3b/b-catenin signaling activation is possibly associated with the translational and post-translational regulation of PTEN Phosphatase and tensin homolog phosphatase function is regulated by a plethora of mechanisms, including transcriptional regulation, post-transcriptional regulation by noncoding RNAs, post-translational modifications, and protein-protein interactions [10] . PTEN transcription is regulated by numerous factors, including NOTCH1, MYC, p53, c-JUN, and SALL4 [29, 30] . Furthermore, PTEN is post-transcriptionally regulated by noncoding RNAs, including miRNA and ceRNAs. PTEN-targeting microRNAs, including miR-19 and miR-21, decrease the PTEN mRNA level via base-pairing with the complementary PTEN sequences [31, 32] . In addition, one ceRNA, PTEN pseudogene1 (PTENP1), acts as a decoy for PTEN-targeting miRNAs [33] [34] [35] . Phosphorylation at Ser380, Thr382, Thr383, or Ser385 of the PTEN C-terminal tail reduces this protein's phosphatase activity but increases its stabilization [10] . Phosphorylation induces a closed, dysfunctional, and more stable PTEN conformation. Our data indicated that PTEN mRNA expression was increased by ethanol treatment at different time intervals and paralleled the change in PTENP1 expression (Fig. 5B) . Then, the p-PTEN and PTEN levels were assessed by western blotting. As shown in Fig. 5A , ethanol adversely affected PTEN and p-PTEN expression in BMSCs. PTEN protein expression was increased, and the p-PTEN level was decreased in the ethanol-treated group compared with the DMSO-treated group in a timedependent manner. In vivo, we also observed that in the osteoprogenitor cells adjacent to trabecular bone, p-PTEN expression was decreased by alcohol while PTEN expression was increased (Fig. 5C,D) . The quantification of positive staining in Fig. 5E ,F revealed similar results (n = 3, *P < 0.05). In summary, our data revealed that both PTEN and PTENP1 mRNA levels were increased in a time-dependent manner following ethanol stimulation, which increased the PTEN protein level. In addition, ethanol increased PTEN expression and decreased p-PTEN expression in a time-dependent manner, which indicated that more functional PTEN was produced.
PTEN inhibition alleviated the antiosteogenic effect of ethanol
To investigate the role of PTEN in the antiosteogenic effect of ethanol, we first evaluate ALP activity in BMSCs following ethanol treatment. The results indicated that ALP activity was decreased by ethanol in a concentration-dependent manner (Fig. 6A) . Next, selective PTEN inhibitors were added to the BMSCs. The amount of ALP-and alizarin red-positive staining was significantly decreased in ethanol-treated BMSCs, whereas PTEN inhibitors alleviated these inhibitory effects (Fig. 6B) . Next, western blotting for COL1 was performed. COL1 protein expression was decreased in BMSCs after ethanol treatment and was increased by cotreatment with PTEN inhibitors (Fig. 6C ). In addition, via ELISA, we found that OPN protein expression was also decreased by ethanol treatment but was increased by PTEN inhibition (Fig. 5D) . Similarly, in vivo, we conducted immunostaining for OCN and COL1 and observed that the number of OCN-and COL1-positive osteoblast-like periosteal cells was decreased in the AL group but was increased in the PTEN inhibitory-treated groups (Fig. 6E,F) . These findings were consistent with our in vitro data. Figure 6G ,H depicts the quantification results. In summary, our data suggested that the ethanolassociated antiosteogenesis was alleviated by PTEN inhibition in BMSCs.
PTEN inhibition rescued the ethanol-induced suppression of bone formation
Bone formation impairment plays a critical role in the pathological process of osteopenia [26, 27] . We next investigated the role of ethanol in new bone formation. The ethanol-induced rat osteopenia model was established by treating rats with ethanol-containing diets [36, 37] . Fluorescent double-labeling was performed, and the relative MAR was calculated [28] . All rats received alizarin red at the beginning of the study and calcein at the end of the 2nd week. Rats were sacrificed during the 4th week, and confocal scanning was performed on hard tissue slices. The results indicated that the amount of newly formed bone tissue was markedly reduced in the AL group compared with the NC group (Fig. 7A , yellow dotted area). However, PTEN inhibition partially increased the new bone formation in the femur condyle (Fig. 7A) . In magnified images (Fig. 7B) , we found that in the AL group, the amount of alizarin red-labeled new bone formation was markedly reduced (both in the cancellous and cortical bone). Alizarin red was injected during the 1st week to label the new bone formed from the 1st to 2nd week. Therefore, this reduced staining might be due to the significant alcohol-induced impairment of new bone formation during the early stage (1st to 2nd week) and a self-compensation mechanism during the late stage (3rd to 4th week). This ethanol effect was also rescued by PTEN inhibition (Fig. 7B) . Interestingly, cortical bone formation was also affected by ethanol. The micro-CT results (Fig. 7C ) and fluorescent double-labeling ( Fig. 7B and D) indicated that cortical bone thickness was decreased in the AL group and was increased in the group treated with PTEN inhibitors. Next, we quantified the cortical bone formation rate via the MAR [28] . MAR was significantly reduced in the cortical bone of the AL group (Fig. 7E) , whereas MAR was increased in the AL+SF1670 and AL+VO-Ohpic groups (Fig. 7E , *P < 0.01).
Ethanol-induced osteopenia was alleviated by PTEN inhibition
To investigate the osteogenic response in vivo, femur samples from the four groups were harvested and histologically examined. Via H&E and Van Gieson staining, we identified ethanol-induced deterioration in the bone architecture. Briefly, a decreased trabecular bone number and reduced cortical bone thickness were observed in ethanol-administered rats (Fig. 8A,B) . Collagen formation is critical for new bone formation and maturation [38, 39] . Masson's trichrome staining was performed to investigate the collagen synthesis in bone tissue. The amount of new bone tissue (blue) was significantly reduced in the distal femur area of the AL group (Fig. 8C ). This observation indicated that collagen synthesis was interrupted by ethanol treatment. These ethanol-induced inhibitory effects on bone formation and collagen synthesis were significantly alleviated by PTEN inhibition (Fig. 8C) . Quantification of new bone tissue in Masson's trichrome staining was depicted in Fig. 8D (n = 3, *P < 0.05). Next, we conducted micro-CT scanning to observe the trabecular bone in the femur condyle and found that bone modeling was significantly impaired in the trabecular bone of the AL group (Fig. 8E,F) . Rat femurs were analyzed using micro-CT. Micro-CT analysis revealed that trabecular BV/TV, BMD, and Tb. Th were significantly reduced while Tb.Sp was concomitantly increased in the AL group compared with the NC group ( Fig. 8G-J) . However, the coadministration of PTEN inhibitors alleviated the antiosteogenic effect of ethanol. In summary, in the rat model, osteogenic activity was significantly reduced by ethanol, but this inhibition was significantly alleviated following PTEN inhibition.
Discussion
The long-term, detrimental effects of alcoholism, including reduced bone mass, are relatively well established [3, 5, 26] . The decreased bone mass and strength following alcohol consumption are mainly due to impairments or imbalances in bone remodeling. However, the mechanisms underlying this effect are not fully understood. Skeletal development and maintenance are mainly regulated by hormones acting on BMSCs, which are multipotent and are regarded as the progenitors of osteoblasts [6] . Our previous work revealed that ethanol impaired the osteogenic differentiation of BMSCs via suppressing the Akt/GSK-3b/ b-catenin pathway [14] . In addition, PTEN expression is increased in alcohol-consuming rats [15, 40, 41] . Furthermore, the regulatory interaction between PTEN and the osteogenic response of bone tissue has been revealed by previous investigations [42] . Based on these findings, we speculated that a close interaction existed among ethanol, PTEN, and the Akt/GSK-3b/b-catenin pathway, which then modulated osteogenesis. In this study, for the first time, we revealed the dual regulation of PTEN by ethanol. First, PTEN and PTENP1 mRNA expression was increased by ethanol in a time-dependent manner, resulting in the increased translation of PTEN protein. In addition, PTEN dephosphorylation revealed that ethanol activates PTEN by post-transcriptional modifications to increase the biological functions of PTEN. Furthermore, our data indicated that the development of alcohol-induced osteopenia is associated with upregulated PTEN activity and Akt/GSK-3b/b-catenin pathway downregulation. PTEN inhibition alleviated alcohol-associated osteopenia via the Akt/GSK-3b/bcatenin pathway.
Phosphatase and tensin homolog phosphatase is a critical tumor suppressor that negatively regulates PI3K/AKT signaling as a lipid phosphatase. Numerous cross-talks between PTEN and various downstream PI3K/AKT signaling targets have been reported. In this study, our data revealed the essential role of PTEN in the regulation of the Akt/GSK-3b/ b-catenin pathway following ethanol treatment. Other studies have demonstrated similar results: the PTEN/ AKT/GSK-3b pathway plays an important role in the regulation of cell proliferation and differentiation [43, 44] . In addition, mammalian target of rapamycin (mTOR), one of the essential downstream targets of PI3K/AKT signaling, is a regulator of cell proliferation and differentiation [45, 46] . Previously, Li et al. found that through mTOR and MAF1 protein regulation, the PTEN/AKT pathway is a central controller of cell growth and human cancer [47] . Similarly, Seront et al. reported that the loss of PTEN function increases cell sensitivity to mTOR inhibitors through the facilitation of PI3K/Akt activation and the consecutive stimulation of the mTOR pathway. In addition, Fig. 6 . PTEN inhibition alleviated the ethanol-induced antiosteogenic effect. (A) Ethanol decreased the ALP activity of hBMSCs in a concentration-dependent manner. Cells were cultured in osteogenic medium containing the indicated concentrations of ethanol for 14 days and ALP activity was measured (three replicates, *P < 0.05). (B) Ethanol impaired the ALP activity and osteogenic differentiation of hBMSCs, but PTEN inhibitors increased these parameters. Cells were cultured in osteogenic medium containing ethanol and/or SF1670 (500 nM) and VO-Ohpic (1 lM) for 14 days. The scale bar equals 100 lm. (C) Ethanol decreased COL1 expression in hBMSCs, whereas PTEN inhibitors increased this expression level. Cells were cultured in osteogenic medium containing ethanol and/or SF1670 (500 nM) and VO-Ohpic (1 lM) for 3 days. GAPDH was used as an internal reference. (D) OPN expression was decreased by ethanol and was increased by PTEN inhibitors. Cells were cultured in osteogenic medium containing ethanol and/or SF1670 (500 nM) and VO-Ohpic (1 lM) for 3 days (three replicates, *P < 0.05). (E,F) Slices were immunostained for OCN and COL1. The results indicated that alcohol consumption increased OCN (yellow arrow) and COL1 (red arrow) expression in periosteal cells. Cell nuclei were stained with DAPI (blue). The scale bar equals 100 lm. (G-H) Quantitation of the number of OCN + or COL1 + periosteal cells in rat distal femur, (n = 5 rats for quantification, *P < 0.05).
Error bars indicate SD.
PI3K and mTOR inhibitors that treat urothelial carcinoma, especially in the absence of functional PTEN, might be useful in clinical trials [48] . Phosphatase and tensin homolog phosphatase is essential for bone formation. Based on our observations, ethanol negatively regulates bone formation and BMSC osteogenic differentiation via PTEN activation. Previous studies by other scientists have indicated that PTEN may contribute to antiapoptosis, proliferation, and differentiation mechanisms in BMSCs [49] . Davis HM et al. demonstrated that the role of PTEN signaling in osteocyte apoptosis, osteoclast formation/ recruitment and skeletal aging [50] . The osteogenesis of osteoblasts has also been reported to be enhanced by PTEN deletion [11] . In summary, PTEN might exert its effect on skeletal remodeling homeostasis via regulating BMSCs, osteoblasts, osteocytes, and osteoclasts. PTEN activity has been poorly studied, and it is not well understood. The protein phosphatase activities of PTEN have been proposed to be important for PTEN autodephosphorylation and autoregulation. Previously, other research groups have identified several proteins, including IRS1, CREB, PTK6, PY342, and the PDGF receptor, as PTEN protein substrates [51] . PTEN is regulated via epigenetic silencing and both transcriptional and post-transcriptional regulation [10, 52] . In the past, investigators found various post-transcriptional modifications of PTEN. PTEN phosphorylation by upstream kinases at Ser229, Thr321, Tyr336, Thr366, Ser370, Ser380, Thr382, Thr383, and Ser385 has been implicated in the modulation of cell biological function, membrane association, and PTEN stability as a tumor suppressor [53] . Phosphorylation of the PTEN C-terminal tail at Ser380, Thr382, Thr383, or Ser385 reduces the phosphatase activity and increases the stabilization of PTEN [52] . PTEN phosphorylation induces a closed, unfunctional conformation that is more stable. In our data, PTENP1 mRNA expression was increased by ethanol, increasing the PTEN mRNA and protein levels. In addition, PTEN protein was activated by ethanol, as evidenced by the decreased phosphorylation level. In summary, ethanol not only increased the expression of PTEN but also activated PTEN via post-transcriptional modifications, increasing the biological functions of this protein.
In summary, through multiple methods, we established the direct and important role of PTEN in the development of alcohol-induced osteoporosis. Our present data suggest that PTEN inhibitors may be used clinically to counteract alcohol-induced bone mineral loss.
Materials and methods

Cell culture
Human BMSCs (hBMSCs) were harvested from donors undergoing total hip arthroplasty surgery as described previously [54] . BMSCs were cultured in a-MEM (Gibco BRL, Grand Island, NY, USA) supplemented with 10% FBS (Invitrogen, Carlsbad, CA, USA) in a humidified cell culture incubator at 37°C and 5% CO2. BMSCs were passaged when they reached 80% confluence. After three to seven passages, BMSCs were used in the following experiments. This study was approved by the Institutional Ethics Review Committee at Shanghai Sixth People's Hospital. Informed consent was obtained from all subjects.
For osteogenic differentiation of hBMSCs, the basal culture medium was supplemented with 10 À2 M b-sodium glycerophosphate, 50 lgÁmL À1 L-ascorbic acid, and 10 À7 M dexamethasone. hBMSCs were induced 48 h after the cells were seeded on culture plates. The osteoblast differentiation medium (osteogenic medium) was changed every 48 h. After 21 days, the cells were fixed and stained with Alizarin Red. MAR was decreased in the AL group and was increased in the AL+SF1670 and AL+VO-Ohpic groups (n = 5 rats for quantification, *P < 0.05). MAR was calculated using IMAGEJ software. Error bars indicate SD.
were harvested, and the Oil Red staining was performed.
ALP activity and alizarin red staining
Cells (1 9 10 5 per well) were seeded on 48-well plates and were grown to 90% confluence. The ALP assay was performed as described previously [54] . ALP activity was measured after 14 days using a microplate test kit (Nanjing Jiancheng Bioengineering Institute, Nanjing, China). For alizarin red staining, 1 9 10 5 BMSCs were seeded on 48-well plates and were grown to 90% confluence. The alizarin red staining was completed as described previously [14] .
Reverse transcription polymerase chain reaction
The PTEN mRNA expression levels were measured using qRT-PCR. The relative expression of the genes was normalized to b-actin expression. The RT-PCR was carried out as described previously [55] . 
Western blotting
Western blotting was performed according to a method described previously [14] . Primary antibodies including anti-PTEN, anti-p-PTEN, anti-p-Akt(Ser473), anti-p-Akt (Thr308), anti-p-GSK3b, anti-GSK3b, anti-b-catenin, and anti-Gapdh were provided by Cell Signaling Technology (CST, Shanghai, China). The anti-Histon-3, anti-OCN, and anti-COL1 antibodies were provided by Proteintech (Shanghai, China). The OPN protein level in BMSCs was detected with enzyme immunoassay (EIA) kits (Boster, Shanghai, China). The sample absorption at 450 nm was analyzed, and a standard curve was generated for each protein. The NE-PER Nuclear and Cytoplasmic Extraction Reagents kit (Pierce Biotechnology, Rockford, IL, USA) was used for nuclear and cytosolic extract preparation as described previously [55] .
Animal grouping and treatment
Forty 8-week-old male specific pathogen-free (SPF) Sprague-Dawley rats were used in this study. All procedures were performed with the approval of the Animal Research Committee at Shanghai Sixth People's Hospital. All methods were performed in accordance with approved guidelines and all efforts were made to minimize suffering and the number of animals used. A Lieber-Decarli, ethanol-containing diet was used to induce osteopenia in the rats [36, 56] . The rats were randomly divided into four groups (10 rats for each group): the normal control group (NC), AL group, alcohol + SF1670 (AL + SF1670) group, and alcohol + VOOhpic (AL + VO-Ohpic) group. Rats in the AL + SF1670 or AL + VO-Ohpic group received i.p. injections of SF1670 (1 lgÁkg
) or VO-Ohpic (10 lgÁkg À1 Áday À1 ), respectively. Rats in the AL group received the ethanol-containing, Lieber-DeCarli liquid diet (FBSH, Shanghai, China), which contained 8% (weight/volume) ethanol (36% of daily calories), fat (38% of daily calories), and protein (17% of daily calories). Rats in the control group were fed a Lieber-DeCarli control diet (the ethanol was substituted with maltodextrin, which contains the same number of calories). This animal experiment lasted 4 weeks, which was used in previous studies [12, 37, 57] . To adapt to the liquid diet, all rats were fed the Lieber-DeCarli liquid diet 1 week prior to the start of the experiment. To minimize differences in the results from food intake, dietary intake was strictly limited to the lowest amount consumed by any group on the previous day. All forty rats had ad libitum access to a liquid diet throughout the study. Diets were prepared fresh daily.
Immunofluorescent staining
Bone mesenchymal stem cells were seeded onto 0.1% gelatin-coated glass cover slips, were placed onto six-well plates, and were allowed to adhere for 48 h. After indicated treatment, the immunofluorescent staining procedure was carried out as described previously [14] . Primary antibodies including anti-OCN were bought from Proteintech, antiAkt and anti-p-Akt (Ser473) were bought from CST (Shanghai, China). The Alexa Fluor TM 488 secondary antibody was purchased from Invitrogen (Shanghai, China). The IgG Control was purchased from Proteintech. Images of cells immunostained with IgG and corresponding secondary antibody were presented in Fig. 9 . Immunofluorescence images were captured using an immunofluorescence microscope ( Leica, Wetzlar, Germany).
For bone tissue specimens, five samples from each rat group were deparaffinized, blocked with 1% BSA, and incubated with anti-OCN (Proteintech), anti-COL1 (Proteintech), anti-PTEN, anti-p-PTEN, and anti-p-Akt(Ser473) primary antibodies for 2 h at room temperature; then, specimens were treated with secondary antibody for 1 h at room temperature. To visualize the cell nucleus, 4 0 ,6-diamidino-2-phenylindole (DAPI) was used. Immunofluorescence images were captured using an immunofluorescence microscope. The quantification procedure was carried out using IMAGEJ software as described previously [21, 22] .
Histological staining
Five bone specimens from each rat group were decalcified using EDTA via constant shaking for 1 month. After decalcification, the bone tissue was embedded in paraffin and was cut into 5-mm-thick sections. To evaluate the subchondral trabecular structure, specimens were stained via the hematoxylin and eosin (H&E), Van Gieson's picrofuchsin and Masson's trichrome methods. A Leica DM 4000 microscope was used to examine the overall morphology of the distal femur.
Fluorescent double-labeling
Fluorescent double labeling was used to detect new bone formation and mineralization. All rats were treated with alizarin red (30 mgÁkg À1 , Sigma-Aldrich, China) at the beginning of the experiment and with calcein (10 mgÁkg À1 , Sigma-Aldrich) at the end of the 2nd week; then, the rats were sacrificed on the 4th week. Samples were processed and images were captured as described previously [55] . The relative mineral apposition rate (MAR) was calculated [28] as previously described.
Micro-CT scanning
Micro-CT scanning of all femurs was performed using a micro-CT scanner set at a 9-micron voxel size. Image acquisition was performed with 35 kV of energy and 220 mA of intensity. Image reconstruction was performed using CTVOL software. The bone mineral density (BMD), trabecular bone volume fraction (BV/TV), trabecular thickness (Tb.Th), and trabecular separation (Tb.Sp) were calculated.
Inhibitors and agonists
Phosphatase and tensin homolog phosphatase inhibitors including SF1670 and VO-Ohpic were purchased from Selleck (Shanghai, China). The SF1670 (500 nM) and VOOhpic (1 lM) concentrations used for in vitro assays were suggested in previous studies [16, 18, 19] . Ly294002, a highly selective PI3K inhibitor [58] , was purchased from Selleck. GSK3b inhibitors, including TWS119 and CHIR-98014, were also purchased from Selleck.
Statistical analysis
Values represent the means AE standard deviation (SD). Data from all groups were analyzed via GRAPHPAD PRISM 7 (San Diego, CA, USA). The significant differences between two groups were examined using Student's t-test. Differences between multiple comparisons were determined by one-way ANOVA with appropriate Bonferroni correction. P-values less than 0.05 were considered statistically significant.
